Trial Profile
An Open Label Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325 After Oral Administration to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2013
Price :
$35
*
At a glance
- Drugs AZD 7325 (Primary)
- Indications Anxiety disorders
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 11 Jun 2008 New trial record.